Technical Analysis for NRSNW - NeuroSense Therapeutics Ltd. - warrant

Grade Last Price % Change Price Change
D 0.18 2.60% 0.00
NRSNW closed up 2.6 percent on Thursday, October 31, 2024, on 17 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Fell Below 50 DMA Bearish 2.60%
20 DMA Support Bullish 2.60%
Wide Bands Range Expansion 2.60%
Gapped Down Weakness 2.60%

   Recent Intraday Alerts

Alert Time
Reversed from Down 2 days ago
20 DMA Support 2 days ago
10 DMA Support 2 days ago
Rose Above 50 DMA 2 days ago
Down 5% 2 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Alzheimer's Disease Parkinson's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Senescence Neurodegenerative Disease Treatment Of Alzheimer's Disease Clinical Neuroscience

Is NRSNW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.55
52 Week Low 0.073
Average Volume 4,032
200-Day Moving Average 0.20
50-Day Moving Average 0.18
20-Day Moving Average 0.16
10-Day Moving Average 0.16
Average True Range 0.04
RSI (14) 52.38
ADX 29.69
+DI 34.03
-DI 25.34
Chandelier Exit (Long, 3 ATRs) 0.13
Chandelier Exit (Short, 3 ATRs) 0.23
Upper Bollinger Bands 0.21
Lower Bollinger Band 0.11
Percent B (%b) 0.66
BandWidth 62.88
MACD Line 0.00
MACD Signal Line -0.01
MACD Histogram 0.0035
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.27
Resistance 3 (R3) 0.26 0.22 0.25
Resistance 2 (R2) 0.22 0.20 0.23 0.25
Resistance 1 (R1) 0.20 0.19 0.18 0.21 0.24
Pivot Point 0.17 0.17 0.16 0.17 0.17
Support 1 (S1) 0.14 0.14 0.12 0.15 0.11
Support 2 (S2) 0.11 0.13 0.11 0.11
Support 3 (S3) 0.08 0.11 0.10
Support 4 (S4) 0.09